Clinical Trials
4 trialsNCT00923442 2026-04-27
Biology Studies of Hematologic Cancers
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT01728402 2026-02-17
Pathogenesis of Hematologic Malignancies
OHSU Knight Cancer Institute
Enrolling by invitation
NCT07383298 2026-02-03
Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase
Peking University People's Hospital
Enrolling by invitation
NCT06646978 2024-10-17
K2SPIRIT
Poitiers University Hospital
Enrolling by invitation